Suppr超能文献

通用药物依从性量表(GMAS)阿拉伯语版本在沙特慢性病患者中的翻译与验证

Translation and validation of the Arabic version of the General Medication Adherence Scale (GMAS) in Saudi patients with chronic illnesses.

作者信息

Naqvi Atta Abbas, Mahmoud Mansour Adam, AlShayban Dhfer Mahdi, Alharbi Fawaz Abdullah, Alolayan Sultan Othman, Althagfan Sultan, Iqbal Muhammad Shahid, Farooqui Maryam, Ishaqui Azfar Athar, Elrggal Mahmoud E, Haseeb Abdul, Hassali Mohamed Azmi

机构信息

Department of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University, Al-Madinah Al-Munawarah, Saudi Arabia.

出版信息

Saudi Pharm J. 2020 Sep;28(9):1055-1061. doi: 10.1016/j.jsps.2020.07.005. Epub 2020 Jul 31.

Abstract

PURPOSE

The study aimed to translate and validate the Arabic version of General Medication Adherence Scale (GMAS) in Saudi patients with chronic diseases.

METHODS

A multi-center cross sectional study was conducted for a month in out-patient wards of hospitals in Khobar, Dammam, Makkah, and Madinah, Saudi Arabia. Patients were randomly selected from a registered patient pools at hospitals and the item-subject ratio was kept at 1:20. The tool was assessed for factorial, construct, convergent, known group and predictive validities as well as, reliability and internal consistency of scale were also evaluated. Sensitivity, specificity, and accuracy were also evaluated. Data were analyzed using SPSS v24 and MedCalc v19.2. The study was approved by concerned ethics committees (IRB-129-25/6/1439) and (IRB-2019-05-002).

RESULTS

A total of 282 responses were received. The values for normed fit index (NFI), comparative fit index (CFI), Tucker Lewis index (TLI) and incremental fit index (IFI) were 0.960, 0.979, 0.954 and 0.980. All values were >0.95. The value for root mean square error of approximation (RMSEA) was 0.059, i.e., <0.06. Hence, factorial validity was established. The average factor loading of the scale was 0.725, i.e., >0.7, that established convergent validity. Known group validity was established by obtaining significant p-value <0.05, for the associations based on hypotheses. Cronbach's α was 0.865, i.e., >0.7. Predictive validity was established by evaluating odds ratios (OR) of demographic factors with adherence score using logistic regression. Sensitivity was 78.16%, specificity was 76.85% and, accuracy of the tool was 77.66%, i.e., >70%.

CONCLUSION

The Arabic version of GMAS achieved all required statistical parameters and was validated in Saudi patients with chronic diseases.

摘要

目的

本研究旨在翻译并验证通用药物依从性量表(GMAS)阿拉伯语版本在沙特慢性病患者中的有效性。

方法

在沙特阿拉伯胡拜尔、达曼、麦加和麦地那的医院门诊病房进行了为期一个月的多中心横断面研究。患者从医院登记的患者库中随机选取,项目与受试者比例保持在1:20。对该工具进行了因子效度、结构效度、收敛效度、已知群体效度和预测效度评估,同时还评估了量表的信度和内部一致性。还评估了敏感性、特异性和准确性。使用SPSS v24和MedCalc v19.2进行数据分析。该研究获得了相关伦理委员会(IRB - 129 - 25/6/1439)和(IRB - 2019 - 05 - 002)的批准。

结果

共收到282份回复。规范拟合指数(NFI)、比较拟合指数(CFI)、塔克·刘易斯指数(TLI)和增量拟合指数(IFI)的值分别为0.960、0.979、0.954和0.980。所有值均>0.95。近似误差均方根(RMSEA)值为0.059,即<0.06。因此,确立了因子效度。量表的平均因子载荷为0.725,即>0.7,确立了收敛效度。基于假设的关联获得了显著的p值<0.05,从而确立了已知群体效度。克朗巴赫α系数为0.865,即>0.7。通过使用逻辑回归评估人口统计学因素与依从性得分的比值比(OR)确立了预测效度。敏感性为78.16%,特异性为76.85%,该工具的准确性为77.66%,即>70%。

结论

GMAS阿拉伯语版本达到了所有所需的统计参数,并在沙特慢性病患者中得到了验证。

相似文献

2
Validation of the General Medication Adherence Scale in Saudi Patients With Chronic Diseases.
Front Pharmacol. 2019 Jun 4;10:633. doi: 10.3389/fphar.2019.00633. eCollection 2019.
3
Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses.
J Drug Assess. 2019 Feb 6;8(1):36-42. doi: 10.1080/21556660.2019.1579729. eCollection 2019.
4
Development and Validation of a Novel General Medication Adherence Scale (GMAS) for Chronic Illness Patients in Pakistan.
Front Pharmacol. 2018 Oct 9;9:1124. doi: 10.3389/fphar.2018.01124. eCollection 2018.
5
Validation of the Arabic Version of General Medication Adherence Scale (GMAS) in Sudanese Patients with Diabetes Mellitus.
Risk Manag Healthc Policy. 2021 Oct 9;14:4235-4241. doi: 10.2147/RMHP.S325184. eCollection 2021.
6
Translation and validation of the Sindhi version of the general medication adherence scale in patients with chronic diseases.
Front Pharmacol. 2023 Sep 20;14:1235032. doi: 10.3389/fphar.2023.1235032. eCollection 2023.
8
Translation and validation of the Chinese version of the general medication adherence scale (GMAS) in patients with chronic illness.
Curr Med Res Opin. 2021 May;37(5):829-837. doi: 10.1080/03007995.2021.1901680. Epub 2021 Mar 27.
9
Validation of the General Medication Adherence Scale in Pakistani Patients With Rheumatoid Arthritis.
Front Pharmacol. 2020 Jul 17;11:1039. doi: 10.3389/fphar.2020.01039. eCollection 2020.
10
Validation of the Arabic version of the general medication adherence scale in patients with type 2 diabetes mellitus in Jordan.
Front Pharmacol. 2023 Sep 20;14:1194672. doi: 10.3389/fphar.2023.1194672. eCollection 2023.

引用本文的文献

1
Medication adherence in Jordanian patients with multimorbidity: a cross-sectional mixed-methods study in outpatient clinics.
Front Pharmacol. 2025 Jul 31;16:1619023. doi: 10.3389/fphar.2025.1619023. eCollection 2025.
2
Medication adherence scales in non-communicable diseases: A scoping review of design gaps, constructs and validation processes.
PLoS One. 2025 May 14;20(5):e0321423. doi: 10.1371/journal.pone.0321423. eCollection 2025.
4
Assessment of Medication Adherence in Diabetes Mellitus Patients at a Tertiary Care Teaching Hospital in India.
Cureus. 2025 Feb 2;17(2):e78391. doi: 10.7759/cureus.78391. eCollection 2025 Feb.

本文引用的文献

1
Validation of the General Medication Adherence Scale in Pakistani Patients With Rheumatoid Arthritis.
Front Pharmacol. 2020 Jul 17;11:1039. doi: 10.3389/fphar.2020.01039. eCollection 2020.
3
Assessment of Medication Adherence in Saudi Patients With Type II Diabetes Mellitus in Khobar City, Saudi Arabia.
Front Pharmacol. 2019 Nov 8;10:1306. doi: 10.3389/fphar.2019.01306. eCollection 2019.
4
Determining known-group validity and test-retest reliability in the PEQ (personalized exercise questionnaire).
BMC Musculoskelet Disord. 2019 Aug 14;20(1):373. doi: 10.1186/s12891-019-2761-3.
6
Validation of the General Medication Adherence Scale in Saudi Patients With Chronic Diseases.
Front Pharmacol. 2019 Jun 4;10:633. doi: 10.3389/fphar.2019.00633. eCollection 2019.
7
Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses.
J Drug Assess. 2019 Feb 6;8(1):36-42. doi: 10.1080/21556660.2019.1579729. eCollection 2019.
8
Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia - a cross-sectional survey.
Patient Prefer Adherence. 2018 Dec 24;13:63-71. doi: 10.2147/PPA.S176355. eCollection 2019.
9
Development and Validation of a Novel General Medication Adherence Scale (GMAS) for Chronic Illness Patients in Pakistan.
Front Pharmacol. 2018 Oct 9;9:1124. doi: 10.3389/fphar.2018.01124. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验